In the manuscript “Retrospective cohort of children and adolescents hospitalized by COVID-19 in Brazil from the beginning of the pandemic to August 1st, 2020”, published in the Rev Bras Epidemiol. 2021; 23: e210026:
Where it reads:
https://doi.org/10.1590/1980-549720200026
It should read:
https://doi.org/10.1590/1980-549720210026
Page 6, 2nd paragraph:
Where it reads:
Considering the distribution of cases according to the FU of residence, Sao Paulo had the highest frequency of hospitalized patients, with 1,320 (26.8%), of which 1,247 (94.5%) recovered and 73 (4.5%) evolved to death. Subsequently the Amazon with 517 (10,5%) hospitalized patients, of which 491 (95,0%) recovered and 26 (5%) died (Figures 2A and 2B and Supplementary Material).
It should read:
Considering the distribution of cases according to the FU of residence, Sao Paulo had the highest frequency of hospitalized patients, with 1.320 (26.8%), of which 1.247 (94.5%) recovered and 73 (4.5%) evolved to death. Subsequently the Amazon with 517 (10.5%) hospitalized patients, of which 491 (95.0%) recovered and 26 (5.0%) died (Figures 2A and 2B and Supplementary Material).
Page 8, 7th paragraph:
Where it reads:
In the bivariate analysis, it was found that they had a higher risk of progressing to death in all the cases that were presented to the following factors: being in the age group of adolescents (RR = OR 1.49; 95% CI 1.26 - 1,78; p < 0.001); - be of the race/color, self-reported black/mixed-brown race (RR = 1.34; 95%CI 1.08 - cop $ 1.68; p < 0.008); it has been ranked as critical-SARS (RR = 4.13; 95%CI 3.43 - 3.96; p < 0.001); have heart disease (RR = WITH 2.07; 95%CI 1.58 - 2.72; p < 0.001), immunopathology (RR = 1.74; 95%CI 1.32 - 2.30; p < 0.001), diabetes (RR= 1.57; 95%CI 1.08 - 2.30; p = 0.032), and neuropathy (RR = 1.47; 95%CI 1.09 - to 1.97; p = 0.013). Asthma was configured as a risk reduction factor for death (RR = 0.25; 95%CI 0.10 - 0.62; p = 0.003 (Table 2).
The other variables that are related to the signs and symptoms of respiratory disease were tested in a bivariate analysis, that is, low oxygen saturation (RR = 4.12; 95%CI 3,33 - 5,09; p < 0.001), respiratory distress (RR = 3.23; 95%CI 2.57 - 4.06; p < 0.001), dyspnea (RR = 3; 95%CI 2.39 - 3.78; p < 0.001), and cyanosis (RR = 2.89; 95%CI 1.66 - 5.05; p = 0.003) (data not shown in table). These variables were grouped in the set of the critical-SARS variable to compose the best regression model.
It should read:
In the bivariate analysis, it was found that they had a higher risk of progressing to death in all the cases that were presented to the following factors: being in the age group of adolescents (RR = 1.49; 95%CI 1.26 - 1.78; p < 0.001); be of the race/color, self-reported black/mixed-brown race (RR = 1.34; 95%CI 1.08 - 1.68; p=0.008); it has been ranked as critical-SARS (RR = 4.13; 95%CI 3.43 - 4.97; p < 0.001); have heart disease (RR = 2.07; 95%CI 1.58 - 2.72; p < 0.001), immunopathology (RR = 1.74; 95%CI 1.32 - 2.30; p < 0.001), diabetes (RR= 1.57; 95%CI 1.08 - 2.30; p = 0.032), and neuropathy (RR = 1.47; 95%CI 1.09 - 1.97; p = 0.013). Asthma was configured as a risk reduction factor for death (RR = 0.22; 95%CI 0.12 - 0.39; p < 0.001 (Table 2).
The other variables that are related to the signs and symptoms of respiratory disease were tested in a bivariate analysis, that is, low oxygen saturation (RR = 4.12; 95%CI 3.33 - 5.09; p < 0.001), respiratory distress (RR = 3.23; 95%CI 2.57 - 4.06; p < 0.001), dyspnea (RR = 3.0; 95%CI 2.39 - 3.78; p < 0.001), and cyanosis (RR = 2.89; 95%CI 1.66 - 5.05; p = 0.003) (data not shown in table). These variables were grouped in the set of the critical-SARS variable to compose the best regression model.
Pages 8 and 10, 9th paragraph:
Where it reads:
Multivariate analysis showed that these associated factors with COVID-19 death remained: belonging to the adolescent age group (RR = 1.59; 95% CI 1.12 - 2.25; p = 0.009), having been classified as SARS-critical (RR = 4.56; 95% CI 2.77 - 7.51; p < 0.001) and having immunopathology (RR = 2.24; 95%CI 1.58 - 3.17; p < 0.001). Asthma remained a factor associated with reduced risk of death (RR = 2.24; 95%CI 1.58 - 3.17; p < 0.001) (Table 2).
It should read:
Multivariate analysis showed that these associated factors with COVID-19 death remained: belonging to the adolescent age group (aRR = 1.59; 95%CI 1.12 - 2.25; p = 0.009), having been classified as SARS-critical (aRR = 4.56; 95%CI 2.77 - 7.51; p < 0.001) and having immunopathology (aRR = 2.24; 95%CI 1.58 - 3.17; p < 0.001). Asthma remained a factor associated with reduced risk of death (aRR = 0.25; 95%CI 0.10 - 0.62; p = 0.003) (Table 2).
Publication Dates
-
Publication in this collection
01 Dec 2021 -
Date of issue
2021
